The role of positron emission tomography in the management of recurrent colorectal cancer: A review

被引:30
作者
Watson, A. J. M.
Lolohea, S.
Robertson, G. M.
Frizelle, F. A.
机构
[1] Christchurch Hosp, Dept Surg, Colorectal Unit, Christchurch, New Zealand
[2] Manchester Royal Infirm, Dept Surg, Manchester M13 9WL, Lancs, England
关键词
positron emission tomography; recurrent colorectal cancer;
D O I
10.1007/s10350-006-0735-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Surgery remains the only option for potential cure in patients with recurrent colorectal cancer. Accurate staging modalities aid in the avoidance of futile surgery, which may result in considerable morbidity in patients with incurable disease. Current imaging techniques used in disease staging often are not sensitive enough to identify low-volume metastatic disease. This study reviews the role of positron emission tomography in the assessment of patients with suspected recurrent colorectal cancer. METHODS: A literature search using the PubMed, MEDLINE, and Embase database was performed, locating English language articles on positron emission tomography, positron emission tomography, recurrent colon, and/or rectal cancer. The references of these papers were searched manually for further references. RESULTS: Positron emission tomography is more sensitive and more specific than conventional diagnostic imaging for metastatic disease and local recurrence respectively. Studies confirm the superior ability of positron emission tomography scans compared with conventional diagnostic imaging in differentiating between scar tissue and invasive tumor. Positron emission tomography scanning is more sensitive and specific for the assessment of liver metastases (and probably in patients with lung metastasis) than conventional diagnostic imaging. Positron emission tomography is superior to conventional diagnostic imaging in the investigation of raised carcinoembryonic antigen in the postoperative patient and alters management in approximately 37 percent of patients with recurrent colorectal cancer. The limitations and cost effectiveness of positron emission tomography are discussed. CONCLUSIONS: Positron emission tomography scanning is emerging as the imaging modality of choice for patients being considered for surgery for locally recurrent colorectal cancer. Positron emission tomography has the greatest impact by detecting unresectable disease and thereby averting inappropriate surgery. Despite the high set-up costs, its use seems to be cost effective.
引用
收藏
页码:102 / 114
页数:13
相关论文
共 102 条
  • [21] TUMOR RECURRENCE VERSUS FIBROSIS IN THE FEMALE PELVIS - DIFFERENTIATION WITH MR IMAGING AT 1.5-T
    EBNER, F
    KRESSEL, HY
    MINTZ, MC
    CARLSON, JA
    COHEN, EK
    SCHIEBLER, M
    GEFTER, W
    AXEL, L
    [J]. RADIOLOGY, 1988, 166 (02) : 333 - 340
  • [22] Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection
    Even-Sapir, E
    Parag, Y
    Lerman, H
    Gutman, M
    Levine, C
    Rabau, M
    Figer, A
    Metser, U
    [J]. RADIOLOGY, 2004, 232 (03) : 815 - 822
  • [23] Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer
    Flamen, P
    Stroobants, S
    Van Cutsem, E
    Dupont, P
    Bormans, G
    De Vadder, N
    Penninckx, F
    Van Hoe, L
    Mortelmans, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 894 - 901
  • [24] Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer
    Flanagan, FL
    Dehdashti, F
    Ogunbiyi, OA
    Kodner, IJ
    Siegel, BA
    [J]. ANNALS OF SURGERY, 1998, 227 (03) : 319 - 323
  • [25] ELEVATED LEVELS OF GLUCOSE-TRANSPORT AND TRANSPORTER MESSENGER-RNA ARE INDUCED BY RAS OR SRC ONCOGENES
    FLIER, JS
    MUECKLER, MM
    USHER, P
    LODISH, HF
    [J]. SCIENCE, 1987, 235 (4795) : 1492 - 1495
  • [26] Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases
    Fong, YM
    Saldinger, PF
    Akhurst, T
    Macapinlac, H
    Yeung, H
    Finn, RD
    Cohen, A
    Kemeny, N
    Blumgart, LH
    Larson, SM
    [J]. AMERICAN JOURNAL OF SURGERY, 1999, 178 (04) : 282 - 287
  • [27] MULTIVARIATE-ANALYSIS OF A PERSONAL SERIES OF 247 CONSECUTIVE PATIENTS WITH LIVER METASTASES FROM COLORECTAL-CANCER .1. TREATMENT BY HEPATIC RESECTION
    FORTNER, JG
    SILVA, JS
    GOLBEY, RB
    COX, EB
    MACLEAN, BJ
    [J]. ANNALS OF SURGERY, 1984, 199 (03) : 306 - 316
  • [28] Fuster D, 2004, J NUCL MED, V45, P1323
  • [29] GALANDIUK S, 1992, SURG GYNECOL OBSTET, V174, P27
  • [30] Gambhir SS, 1996, J NUCL MED, V37, P1428